Alcon introduces ThromboGenics’ Jetrea in Denmark, Sweden
Alcon expects to roll out the European Commission approved Jetrea, which is indicated for the treatment of vitreomacular traction (VMT), next in Finland and Norway while the product
The US Food and Drug Administration (FDA) has declined to approve Unicycive Therapeutics’ resubmitted new drug application (NDA) for oxylanthanum carbonate (OLC) to treat hyperphosphatemia in chronic kidney disease (CKD) patients on dialysis.
Delivering corrective measures in real-time, the critical modules loaded Goose Quality Manager assists in dealing with non-conformances, internal and external audits, change management, corrective action and preventive action